Wolverine Trading
AGN

Wolverine Trading’s Allergan plc AGN Stock Holding History

Wolverine Trading’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-58,655
Closed -$11.2M – 5676
2019
Q4 		$11.2M Sell
58,655
-14,215
-20% -$2.56M 0.03% 627
2019
Q3 		$12.3M Sell
72,870
-17,298
-19% -$2.82M 0.04% 445
2019
Q2 		$15.1M Buy
90,168
+30,253
+50% +$4.19M 0.04% 376
2019
Q1 		$8.77M Buy
59,915
+41,589
+227% +$6.03M 0.03% 552
2018
Q4 		$2.43M Sell
18,326
-2,474
-12% -$406K 0.01% 1266
2018
Q3 		$3.96M Sell
20,800
-25,550
-55% -$4.69M 0.01% 1135
2018
Q2 		$7.8M Hold
46,350
– – 0.02% 617
2018
Q1 		$7.8M Sell
46,350
-21,452
-32% -$3.6M 0.02% 617
2017
Q4 		$11.1M Buy
67,802
+29,909
+79% +$5.37M 0.04% 465
2017
Q3 		$7.77M Buy
37,893
+26,827
+242% +$6.24M 0.03% 535
2017
Q2 		$2.7M Sell
11,066
-7,194
-39% -$1.69M 0.01% 1039
2017
Q1 		$4.38M Buy
18,260
+15,018
+463% +$3.5M 0.02% 709
2016
Q4 		$681K Buy
+3,242
New +$672K ﹤0.01% 2290

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wolverine Trading's AGN Position: Q1 2020 in Review

Wolverine Trading sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 58,655 shares — an estimated $11.2M sold.

Wolverine Trading first reported a position in AGN in Q4 2016 and held it in 13 quarters. The position peaked at $15.1M in Q2 2019. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Wolverine Trading reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 58,655 Allergan plc shares in Q1 2020, an estimated $11.2M.
  • Wolverine Trading first reported a position in Allergan plc in Q4 2016 and held it in 13 quarters.
  • Wolverine Trading's Allergan plc position peaked at $15.1M in Q2 2019.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.